β-Blockers and Primary Prevention of Coronary Heart Disease in Patients With High Blood Pressure

Bruce M. Psaty, Thomas D. Koepsell, James P. Logerfo, Edward H. Wagner, Thomas Inui

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

We conducted a population-based, case-control study to determine whether β-blockers, used for the treatment of hypertension, prevent first events of coronary heart disease. Cases were patients who had high blood pressure treated with medicines and who presented in 1982 to 1984 with angina or fatal or nonfatal myocardial infarction. Controls were a probability sample of health maintenance organization patients with pharmacologically treated hypertension and free of coronary heart disease. Blinded to case-control status, we reviewed the medical records of the 248 cases and 737 controls. The health maintenance organization’s computerized pharmacy database was used to ascertain the use of β-blockers. Fewer cases than controls were taking β-blockers. This difference was confined to those with nonfatal infarctions. After adjustment for confounding, the estimated relative risk was 0.62 (95% confidence interval, 0.39 to 0.99). Higher doses of β-blockers conferred greater protection. We conclude that β-blockers may prevent first events of nonfatal myocardial infarction in patients with high blood pressure.

Original languageEnglish (US)
Pages (from-to)2087-2094
Number of pages8
JournalJournal of the American Medical Association
Volume261
Issue number14
DOIs
StatePublished - Apr 14 1989
Externally publishedYes

Fingerprint

Primary Prevention
Coronary Disease
Hypertension
Health Maintenance Organizations
Myocardial Infarction
Sampling Studies
Infarction
Medical Records
Case-Control Studies
Databases
Confidence Intervals
Population
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

β-Blockers and Primary Prevention of Coronary Heart Disease in Patients With High Blood Pressure. / Psaty, Bruce M.; Koepsell, Thomas D.; Logerfo, James P.; Wagner, Edward H.; Inui, Thomas.

In: Journal of the American Medical Association, Vol. 261, No. 14, 14.04.1989, p. 2087-2094.

Research output: Contribution to journalArticle

Psaty, Bruce M. ; Koepsell, Thomas D. ; Logerfo, James P. ; Wagner, Edward H. ; Inui, Thomas. / β-Blockers and Primary Prevention of Coronary Heart Disease in Patients With High Blood Pressure. In: Journal of the American Medical Association. 1989 ; Vol. 261, No. 14. pp. 2087-2094.
@article{217a5e08704f46e4af1fd63d56ee2da0,
title = "β-Blockers and Primary Prevention of Coronary Heart Disease in Patients With High Blood Pressure",
abstract = "We conducted a population-based, case-control study to determine whether β-blockers, used for the treatment of hypertension, prevent first events of coronary heart disease. Cases were patients who had high blood pressure treated with medicines and who presented in 1982 to 1984 with angina or fatal or nonfatal myocardial infarction. Controls were a probability sample of health maintenance organization patients with pharmacologically treated hypertension and free of coronary heart disease. Blinded to case-control status, we reviewed the medical records of the 248 cases and 737 controls. The health maintenance organization’s computerized pharmacy database was used to ascertain the use of β-blockers. Fewer cases than controls were taking β-blockers. This difference was confined to those with nonfatal infarctions. After adjustment for confounding, the estimated relative risk was 0.62 (95{\%} confidence interval, 0.39 to 0.99). Higher doses of β-blockers conferred greater protection. We conclude that β-blockers may prevent first events of nonfatal myocardial infarction in patients with high blood pressure.",
author = "Psaty, {Bruce M.} and Koepsell, {Thomas D.} and Logerfo, {James P.} and Wagner, {Edward H.} and Thomas Inui",
year = "1989",
month = "4",
day = "14",
doi = "10.1001/jama.1989.03420140089033",
language = "English (US)",
volume = "261",
pages = "2087--2094",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "14",

}

TY - JOUR

T1 - β-Blockers and Primary Prevention of Coronary Heart Disease in Patients With High Blood Pressure

AU - Psaty, Bruce M.

AU - Koepsell, Thomas D.

AU - Logerfo, James P.

AU - Wagner, Edward H.

AU - Inui, Thomas

PY - 1989/4/14

Y1 - 1989/4/14

N2 - We conducted a population-based, case-control study to determine whether β-blockers, used for the treatment of hypertension, prevent first events of coronary heart disease. Cases were patients who had high blood pressure treated with medicines and who presented in 1982 to 1984 with angina or fatal or nonfatal myocardial infarction. Controls were a probability sample of health maintenance organization patients with pharmacologically treated hypertension and free of coronary heart disease. Blinded to case-control status, we reviewed the medical records of the 248 cases and 737 controls. The health maintenance organization’s computerized pharmacy database was used to ascertain the use of β-blockers. Fewer cases than controls were taking β-blockers. This difference was confined to those with nonfatal infarctions. After adjustment for confounding, the estimated relative risk was 0.62 (95% confidence interval, 0.39 to 0.99). Higher doses of β-blockers conferred greater protection. We conclude that β-blockers may prevent first events of nonfatal myocardial infarction in patients with high blood pressure.

AB - We conducted a population-based, case-control study to determine whether β-blockers, used for the treatment of hypertension, prevent first events of coronary heart disease. Cases were patients who had high blood pressure treated with medicines and who presented in 1982 to 1984 with angina or fatal or nonfatal myocardial infarction. Controls were a probability sample of health maintenance organization patients with pharmacologically treated hypertension and free of coronary heart disease. Blinded to case-control status, we reviewed the medical records of the 248 cases and 737 controls. The health maintenance organization’s computerized pharmacy database was used to ascertain the use of β-blockers. Fewer cases than controls were taking β-blockers. This difference was confined to those with nonfatal infarctions. After adjustment for confounding, the estimated relative risk was 0.62 (95% confidence interval, 0.39 to 0.99). Higher doses of β-blockers conferred greater protection. We conclude that β-blockers may prevent first events of nonfatal myocardial infarction in patients with high blood pressure.

UR - http://www.scopus.com/inward/record.url?scp=0024514133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024514133&partnerID=8YFLogxK

U2 - 10.1001/jama.1989.03420140089033

DO - 10.1001/jama.1989.03420140089033

M3 - Article

VL - 261

SP - 2087

EP - 2094

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 14

ER -